• Most Popular
  • Most Shared
A huge poster with a red ribbon symbolizing the fight against AIDS is displayed on the facade of the Palace of Culture ahead of World AIDS Day in Warsaw November 27, 2009. REUTERS/Kacper Pempe

HIV case exposes insurer policy

When Jerome Mitchell successfully sued his insurance company after it revoked his policy, he exposed a wrongdoing that could have repercussions for the entire health insurance industry.  Full Article 

    Oct flu vaccination to be "a little bumpy": U.S.

    CHICAGO
    Fri Sep 25, 2009 5:05pm EDT
    A doctor prepares a syringe in this file photo. REUTERS/Eric Gaillard

    A doctor prepares a syringe in this file photo.

    Credit: Reuters/Eric Gaillard

    CHICAGO (Reuters) - A top U.S. health official says the first weeks of October are going to be "a little bumpy" as the government distributes the supply the swine flu vaccine ready next week -- knowing it will not be enough.

    Health  |  Swine Flu

    Dr. Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, said on Friday his agency faced a dilemma because most of the U.S. H1N1 vaccine will be unavailable until mid- to late October.

    "The choice was having vaccine stack up in a warehouse ... or getting it out as soon as it became available. We feel the only right answer is to get it out as rapidly as possible," Frieden told reporters in a telephone briefing.

    But that move will add to the strain on state and local health departments that likely will have to turn people away.

    "It's going to be a little bumpy," said Frieden.

    The U.S. government said this week it will have 6 million to 7 million doses of swine flu vaccine ready next week, and another 40 million does by mid- to late October.

    Production was expected to continue at a rate of 10 million to 20 million doses per week to a total of more than 250 million by year end.

    Most of the vaccine that will be ready early will be the nasal spray vaccine made by AstraZeneca's MedImmune unit. It is approved for people aged 2-49, but is not recommended for people with certain underlying health problems, who have a higher risk of becoming severely ill if infected with the flu.

    'BATCH BY BATCH'

    The United States has ordered vaccine from five companies -- MedImmune, Sanofi-Aventis, Australia's CSL, GlaxoSmithKline and Novartis.

    Frieden said the problem arose from working with different manufacturers. "It doesn't come out in one big drop. It comes out batch by batch," he said.

    Frieden said vaccine was the best tool for fighting swine flu, which was declared a pandemic in June and is spreading widely in most of the United States.

    Frieden urged Americans not to underestimate influenza, noting that many people mix up flu with mild respiratory viruses.

    "Flu makes you pretty sick. You feel bad. If you've got an underlying health problem or you are unlucky, you can get very sick. You need to take the flu seriously," Frieden said.

    Frieden addressed concerns about an unpublished study reported by Canadian media suggesting that people in Canada who were vaccinated against seasonal flu last spring had double the risk of becoming infected with pandemic H1N1 flu.

    Frieden said the CDC has analyzed data from New York and other parts of the United States and data from Australia.

    "Nothing we've seen suggest that is likely to be a problem," he said. "If there is preliminary data, we'd like to see it."

    (Editing by Maggie Fox and Xavier Briand)



    More from Reuters

    Photo

    Health overhaul to cut deficit by $100 billion: Hoyer

    WASHINGTON (Reuters) - House Majority Leader Steny Hoyer said on Thursday that sweeping healthcare overhaul legislation was on track for passage by the U.S. House of Representatives and would cut the deficit by more than $100 billion in the first 10 years.

    Jeff Kindler, CEO of Pfizer Inc., speaks at the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 1, 2009. REUTERS/Brian Snyder

    Pfizer: "We've begun to change"

    Pfizer CEO Jeff Kindler says businesses -- including his -- need to earn back the public's trust because their survival depends on it.  Commentary 

    North Korean leader Kim Jong-il claps during a mass rally in Hamhung Square to celebrate the completion of the February 8 Vinalon Complex in Hamhung in South Hamgyong Province March 6, 2010 in this picture released by the North's KCNA news agency on March 7, 2010.  Credit: Reuters/KCNA

    Kim may ramp up scare tactics

    North Korea's Kim Jong-il is in one of the riskiest periods of his iron rule. Should the West be afraid?  Full Article